UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000059501 |
|---|---|
| Receipt number | R000068049 |
| Scientific Title | Blood kinetics study of single intake of plant extract |
| Date of disclosure of the study information | 2025/10/22 |
| Last modified on | 2025/10/22 14:13:46 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Blood kinetics study of single intake of plant extract
Acronym
Blood kinetics study of single intake of plant extract
Scientific Title
Blood kinetics study of single intake of plant extract
Scientific Title:Acronym
Blood kinetics study of single intake of plant extract
Region
| Japan |
Condition
Condition
Healthy adults
Classification by specialty
| Not applicable | Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To investigate the absorption of active compounds in blood following a single oral administration of a plant extract.
Basic objectives2
Pharmacokinetics
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Incremental area under the serum concentration time curve (iAUC) from the pre dose baseline for the active compounds from plant extract.
Key secondary outcomes
Maximum serum concentration (Cmax) of the active compounds from plant extract; serum concentration at each blood-sampling time point; time to reach maximum serum concentration (Tmax); and elimination half-life (t1/2) of the active compounds from plant extract.
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Prevention
Type of intervention
| Food |
Interventions/Control_1
Single intake of test food
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 60 | years-old | > |
Gender
Male and Female
Key inclusion criteria
1) Men and women aged 20 to 60 years old at the time of obtaining consent
2) BMI of 18.5 kg/m2 or more and less than 25.0 kg/m2
3) Subjects who can participate in dietary interventions, intake of the test foods, blood samplings, urine samplings, and maintain rest as scheduled.
4) Subjects with decisional capacity to provide informed consent
Key exclusion criteria
1)Subjects with a serious medical history, or with a history of disorders of the digestive system, circulatory system (e.g., heart failure), endocrine system, etc.
2)Subjects who have a history of gastrointestinal resection surgery, excluding appendectomy.
3)Subjects who have a disease that affects gastric excretion and digestion/absorption, or who regularly experience symptoms of indigestion, constipation, diarrhea, etc.
4) Subjects with abnormalities in renal function, liver function, blood pressure, glucose and lipid metabolism
5)Subjects who are currently taking medication or being treated by a physician.
6)Subjects who must be scheduled to receive medical treatment or medication during the study period.
7)Subjects who plan to consume health foods or supplements other than the food under study after consent.
8)Subjects who are unable to consume the test food due to preference or allergy. Subjects who may have allergies related to the test food.
9)Heavy drinkers of alcohol and smokers.
10)Subjects who donated blood over 200mL in the past 4 weeks or over 400mL in the past 12 weeks.
11)Subjects who currently or will be participating in another clinical research study during the study period.
12)Subjects who have irregular sleep or eating habits due to night work or insomnia.
13)Subjects who are engaged in strenuous physical activity.
14)Subjects judged as unsuitable for the study by the responsible doctor for other reasons.
Target sample size
20
Research contact person
Name of lead principal investigator
| 1st name | Erika |
| Middle name | |
| Last name | Ono |
Organization
FANCL Corporation
Division name
Research Institute, Functional Food Research Institute
Zip code
244-0806
Address
12-13, Kamishinano, Totsuka-ku, Yokohama, Kanagawa, Japan
TEL
045-820-3448
erono@fancl.co.jp
Public contact
Name of contact person
| 1st name | Naoyuki |
| Middle name | |
| Last name | Abe |
Organization
Medical Corporation Jikokai Shiroishi Internal Medicine Clinic
Division name
Clinical Trial Division
Zip code
003-0011
Address
7-10-30 Chuo-1 jo, Shiroishi-ku, Sapporo, Hokkaido, Japan
TEL
011-868-2711
Homepage URL
n-abe@medi-ate.jp
Sponsor or person
Institute
FANCL Corporation
Institute
Department
Personal name
Funding Source
Organization
FANCL Corporation
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Japan
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Medical Corporation Jikokai Fukuzumi Internal Medicine Clinic Institutional Review Board
Address
1-2-5 Fukuzumi-2 jo, Toyohira-ku, Sapporo, Hokkaido, Japan
Tel
011-836-3531
n-abe@medi-ate.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
医療法人社団慈昂会 白石内科クリニック
Other administrative information
Date of disclosure of the study information
| 2025 | Year | 10 | Month | 22 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2025 | Year | 10 | Month | 03 | Day |
Date of IRB
| 2025 | Year | 10 | Month | 10 | Day |
Anticipated trial start date
| 2025 | Year | 10 | Month | 20 | Day |
Last follow-up date
| 2025 | Year | 11 | Month | 16 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2025 | Year | 10 | Month | 22 | Day |
Last modified on
| 2025 | Year | 10 | Month | 22 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068049
